Institution statistics

DEUTSCHES KREBSFORSCHUNGSZENTRUM - Germany 

Ranking results:

Past rankings:
2019
Criterium:Position:
Overall Score:100-200
Total Project Funding per Partner:100-200
Total Number of Projects:200-300
2018
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:> 1000
Total Number of Projects:> 1000
Networking Rank (Reputation):> 1000
2017
Criterium:Position:
Overall Score:300-400
Total Project Funding per Partner:100-200
Total Number of Projects:300-400
Networking Rank (Reputation):600-700
2016
Criterium:Position:
Overall Score:600-700
Total Project Funding per Partner:200-300
Total Number of Projects:500-600
Networking Rank (Reputation):> 1000
2015
Criterium:Position:
Overall Score:200-300
Total Project Funding per Partner:200-300
Total Number of Projects:400-500
Networking Rank (Reputation):> 1000
Partner Constancy:300-400
Project Leadership Index:82
2013
Criterium:Position:
Overall Score:300-400
Total Project Funding per Partner:200-300
Total Number of Projects:64
Total Project Funding:300-400
Partner Constancy:58
Project Leadership Index:47
Diversity Index:47
2012
Criterium:Position:
Overall Score:500-600
Total Project Funding per Partner:100-200
Total Number of Projects:61
Total Project Funding:200-300
Networking Rank (Reputation):300-400
Networking Rank (Reputation):300-400
Partner Constancy:46
Project Leadership Index:75
Diversity Index:37
2011
Criterium:Position:
Overall Score:600-700
Total Project Funding per Partner:400-500
Total Number of Projects:300-400
Total Project Funding:400-500
Networking Rank (Reputation):400-500
Partner Constancy:700-800
Project Leadership Index:200-300
Diversity Index:> 1000
2010
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:100-200
Total Number of Projects:500-600
Total Project Funding:400-500
Networking Rank (Reputation):> 1000
Partner Constancy:500-600
Project Leadership Index:600-700
Diversity Index:> 1000
2009
Criterium:Position:
Overall Score:400-500
Total Project Funding per Partner:100-200
Total Number of Projects:200-300
Total Project Funding:200-300
Networking Rank (Reputation):200-300
Partner Constancy:600-700
Project Leadership Index:600-700
Diversity Index:300-400
2008
Criterium:Position:
Overall Score:300-400
Total Project Funding per Partner:100-200
Total Number of Projects:200-300
Total Project Funding:100-200
Networking Rank (Reputation):200-300
Partner Constancy:200-300
Project Leadership Index:300-400
Diversity Index:> 1000
2007
Criterium:Position:
Overall Score:900-1000
Total Project Funding per Partner:100-200
Total Number of Projects:200-300
Total Project Funding:300-400
Networking Rank (Reputation):400-500
Partner Constancy:500-600
Project Leadership Index:600-700
Diversity Index:> 1000
Ranking timeline:

European project participation (2010-01-01 - 2021-12-31 ):

Performance:

Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:
Leadership:

Total number of projects: 89
As coordinator: 6
As participant: 60
Sole participant: 23
Coordinator / Participant Ratio: 0.1*

*Ratio includes only projects with > 2 partners

Summary:
Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2021 3.000.000 0 3.000.000 2
2020 324.806 20.084.179 2.519.865 2 4
2019 16.057.200 56.823.039 11.893.624 5 8
2018 3.820.336 12.520.105 2.083.518 4 4
2017 9.376.250 8.759.860 4.500.000 2 4
2016 1.738.955 11.293.830 4.178.127 2 4
2015 2.168.794 38.787.645 6.127.881 2 8
2014 261.969 0 261.969 2
2013 6.195.747 35.879.301 4.334.619 3 7
2012 336.754 46.735.876 9.167.323 2 10
2011 8.098.428 25.638.979 3.387.602 3 5
2010 0 44.806.245 5.263.164 6
*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:
Institution:Projects [No]:
EUROPEAN MOLECULAR BIOLOGY LABORATORY9
UNIVERSITAETSKLINIKUM HEIDELBERG9
IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE7
CHARITE UNIVERSITAETSMEDIZIN BERLIN6
KAROLINSKA INSTITUTE6
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD6
UNIVERSITY COLLEGE LONDON6
INSTITUT CURIE5
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE5
INTERNATIONAL AGENCY FOR RESEARCH ON CANCER5
RUPRECHT KARLS UNIVERSITAET HEIDELBERG5
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF CAMBRIDGE5
ASSISTANCE PUBLIQUE HOPITAUX DE PARIS4
ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM4
INSTITUT CATALA D'ONCOLOGIA4
ISTITUTO NAZIONALE PER LO STUDIO E LA CURA DEI TUMORI4
STICHTING HET NEDERLANDS KANKER INSTITUUTANTONI VAN LEEUWENHOEK ZIEKENHUIS4
THE UNIVERSITY OF MANCHESTER4
UNIVERSITAET ZUERICH4
UNIVERSITEIT GENT4
VTT TECHNICAL RESEARCH CENTRE OF FINLAND4
CENTRE DE REGULACIO GENOMICA3
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE3
CONSIGLIO NAZIONALE DELLE RICERCHE3
FUNDACIO PRIVADA INSTITUT D'INVESTIGACIO ONCOLOGICA DE VALLHEBRON3
KATHOLIEKE UNIVERSITEIT LEUVEN3
KUNGLIGA TEKNISKA HOEGSKOLAN3
LUNDS UNIVERSITET3
MAX PLANCK GESELLSCHAFT ZUR FOERDERUNG DER WISSENSCHAFTEN EV3
PRINSES MAXIMA CENTRUM VOOR KINDERONCOLOGIE BV3
THE UNIVERSITY OF WARWICK3
UMEA UNIVERSITET3
UNIVERSITAIR MEDISCH CENTRUM UTRECHT3
UNIVERSITEIT MAASTRICHT3
UNIVERSITY COLLEGE DUBLIN NATIONAL UNIVERSITY OF IRELAND DUBLIN3
UNIVERSITY OF COPENHAGEN3
UNIVERSITY OF TROMSOE3
UPPSALA UNIVERSITET3
ACADEMISCH ZIEKENHUIS GRONINGEN2
BARCELONA SUPERCOMPUTING CENTER CENTRO NACIONAL DE SUPERCOMPUTACION2
BAYER2
COMMISSARIAT A L'ENERGIE ATOMIQUE2
COMMISSION OF THE EUROPEAN COMMUNITIES DIRECTORATE GENERAL JOINT RESEARCH CENTRE JRC2
CONSORCI INSTITUT D'INVESTIGACIONS BIOMEDIQUES AUGUST PI I SUNYER2
DANISH CANCER SOCIETY2
DEUTSCHES INSTITUT FUER ERNAEHRUNGSFORSCHUNG2
FOUNDATION FOR GENOMICS & POPULATION HEALTH2
FRAUNHOFER GESELLSCHAFT ZUR FOERDERUNG DER ANGEWANDTEN FORSCHUNG E V2
FUNDACION CENTRO NACIONAL DE INVESTIGACIONES ONCOLOGICAS CARLOS III2
FUNDACION PARA LA INVESTIGACION MEDICA APLICADA2
GATC BIOTECH2
GENETHON2
GOETEBORGS UNIVERSITET2
GSF FORSCHUNGSZENTRUM FUER UMWELT UND GESUNDHEIT2
HELLENIC HEALTH FOUNDATION2
HITS GGMBH2
IBM RESEARCH2
INSTITUT GUSTAVE ROUSSY2
ISTITUTO EUROPEO DI ONCOLOGIA2
LUDWIG MAXIMILIANS UNIVERSITAET MUENCHEN2
NATIONAL UNIVERSITY OF IRELAND GALWAY2
OSLO UNIVERSITETSSYKEHUS HF2
RIJKSINSTITUUT VOOR VOLKSGEZONDHEIDEN MILIEUNATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT2
SERVICIO MADRILENO DE SALUD2
ST ANNA KINDERKREBSFORSCHUNG2
STICHTING VU2
TECHNISCHE UNIVERSITAET MUENCHEN2
THE BABRAHAM INSTITUTE2
THE CHRISTIE NHS FOUNDATION TRUST2
THE UNIVERSITY OF AUCKLAND2
UNIVERSIDAD DE NAVARRA2
UNIVERSIDAD DEL PAIS VASCO/ EUSKAL HERRIKO UNIBERTSITATEA2
UNIVERSITA DEGLI STUDI DI ROMA TOR VERGATA2
UNIVERSITAETSKLINIKUM ESSEN2
UNIVERSITE DE LAUSANNE2
UNIVERSITEIT LEIDEN2
UNIVERSITEIT VAN AMSTERDAM2
UNIVERSITY OF BIRMINGHAM2
UNIVERSITY OF GLASGOW2
UNIVERSITY OF LEEDS2
UNIVERSITY OF TURKU2
WAGENINGEN UNIVERSITY2
10X GENOMICS INC1
ABRO BIOTEC SL1
ACADEMIC MEDICAL CENTRE AMSTERDAM1
ACADEMISCH ZIEKENHUIS LEIDEN1
ACONDICIONAMIENTO TARRASENSE ASSOCIACION1
ADEXGO IPARI KERESKEDELMI ES SZOLGALTATO KFT1
ADWARE RESEARCH FEJLESZTO ES TANACSADO KFT1
AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS1
AIN SHAMS UNIVERSITY ASU FACULTY OF MEDECINE1
ALACRIS THERANOSTICS1
ALMAZOV FEDERAL HEART BLOOD AND ENDOCRINOLOGY CENTRE FEDERATION AGENCY ON HIGH MEDICAL TECHNOLOGIES1
ALTA RICERCA E SVILUPPO IN BIOTECNOLOGIE SRL ALTA1
AMSTERDAM MOLECULAR THERAPEUTICS BV1
ANAXOMICS BIOTECH S L1
APOGENIX1
APPLICATIONS SANTE DES LIPIDES SARL1
ARISTOTLE UNIVERSITY OF THESSALONIKI1
ARTTIC1
Constancy:

Total number of partners:565

Partner loyalty:
Frequent Partner: (> 2 projects): 161
Rare Partner: 404

Frequent / Rare Partner Ratio: 0.4

Diversity:

Categories:
Category:No:
BIOLOGICAL SCIENCES27
RTD HORIZONTAL TOPICS10
INDUSTRY AND TECHNOLOGY2
SOCIAL AND ECONOMIC CONCERNS1

Project overview:

Start dateProjectacronymrolefundingpartners
2021-01-01DNA Breaks Shape Neural Genome Heterogeneity BrainBreakscoordinator1.500.0001
2021-01-01Dissecting the Functional and Therapeutic Impact of Somatic Copy Number Alterations (SCNAs) CrispSCNAscoordinator1.500.0001
2020-12-01Validation of Actionable Genomic ABerrations in a paediatric Oncology Network for Doctorate students VAGABONDparticipant3.989.71311
2020-12-01ROles of ePitranscriptomic in diseasES ROPESparticipant3.095.82911
2020-09-01Single Cell EPigenomic, Transcriptomic, and structural Rearrangement profiling to investigate Evolution in prostate cancer SCEPTREcoordinator174.8061
2020-07-01Generating monoclonal antibodies that selectively and specifically recognize epitranscriptomic modifications. EPIMODKITcoordinator150.0002
2020-01-014-IN THE LUNG RUN: towards INdividually tailored INvitations, screening INtervals, and INtegrated co-morbidity reducing strategies in lung cancer screening 4-IN THE LUNG RUNparticipant7.999.9499
2020-01-01HCA|Organoid: Pilot action to establish a multi-tissue human organoid platform within the Human Cell Atlas as a booster of future disease-centric, mechanistic, and translational research HCA Organoidparticipant4.998.6888
2019-07-01Decoding Context-Dependent Genetic Networks in vivo DECODEcoordinator10.625.0003
2019-06-01The strong interaction at the frontier of knowledge: fundamental research and applications STRONG-2020participant10.000.00044
2019-05-01Matching CNS Lineage Maps with Molecular Brain Tumor Portraits for Translational Exploitation BRAIN-MATCHcoordinator1.999.8751
2019-03-01European network staff eXchange for integrAting precision health in the health Care sysTems ExACTparticipant1.090.20018
2019-02-01Safeguarding Cell Fate by Terminal Repression during Development and Disease SafeFatecoordinator1.761.4891
2019-02-01European Advanced infraStructure for Innovative Genomics EASI-Genomicsparticipant9.991.26716
2019-01-24Clarifying role of the CENTROSOME in abnormal mitotic processes featuring the most commonchildhood malignancy: paediatric High Hyperdiploid Acute Lymphoblastic Leukaemia (HHDpALL) CENTR-ALLcoordinator171.4611
2019-01-01individualizedPaediatricCure: Cloud-based virtual-patient models for precision paediatric oncology iPCparticipant14.748.40021
2019-01-01EUCANCan: a federated network of aligned and interoperable infrastructures for the homogeneous analysis, management and sharing of genomic oncology data for Personalized Medicine. EUCANCanparticipant5.999.45318
2019-01-01Targeting genetic and epigenetic mechanisms in pediatric sarcomas. PedSarccoordinator1.499.3751
2019-01-01Translational studies of HEAD and neck cancer in South America and Europe HEADSpAcEparticipant3.153.44815
2019-01-01ARCHITECTURE AND TOOLS FOR THE QUERY OF ANTIBODY AND T-CELL RECEPTOR SEQUENCING DATA REPOSITORIES FOR ENABLING IMPROVED PERSONALIZED MEDICINE AND IMMUNOTHERAPY iReceptor Plusparticipant7.856.92520
2019-01-01Project on Exercise for Fatigue Eradication in Advanced Breast cancer to improve quality of life PREFERABLEparticipant3.983.34712
2018-09-01Quantitative T cell Immunology and Immunotherapy QuanTIIparticipant3.923.65310
2018-08-01Mechanisms of vascular maturation and quiescence during development, homeostasis and aging AngioMatureparticipant2.338.9182
2018-08-01Image-based analysis for drug discovery and repurposing REMATCHcoordinator149.5001
2018-07-01Mechanism and vulnerability of BAP1 loss in tumor metastasis VulneraBAP1coordinator171.4611
2018-06-01Come and Play Science at European Researchers` Night QriUSparticipant307.57010
2018-06-01Exploring cell interactions in the tumor microenvironment with dual ribosome profiling DualRPcoordinator1.499.3751
2018-06-01Redirecting glial progenitor fate to rebuild the injured Brain REBUILDCNScoordinator2.000.0001
2018-01-01Systems Medicine of Metabolic-Signaling Networks: A New Concept for Breast Cancer Patient Stratification MESI-STRATparticipant5.949.96415
2017-10-01Detecting, understanding and exploiting intracellular redox signaling relays Redox Relayscoordinator2.006.2501
2017-10-01A new era in personalised medicine: Radiomics as decision support tool for diagnostics and theragnostics in oncology PREDICTparticipant3.860.06018
2017-09-01Centre of Excellence in Digital Health and Personalised Medicine Clinnovaparticipant399.8005
2017-07-01Endogenous barcoding for in vivo fate mapping of lineage development in the blood and immune system BARCODED-CELLTRACINGparticipant2.500.0001
2017-03-01Regulation of Cellular Growth and Metabolism by C18:0 C18Signalingparticipant2.000.0001
2017-01-01ITCC Pediatric Preclinical POC Platform – Sofia ref.: 116064 ITCC-P4coordinator7.370.00021
2016-11-07Deciphering the machinery involved in stability of the transcription factor HOXA9. HOXA9 degradomecoordinator239.8611
2016-06-01Overcoming the epigenetic and therapeutic barrier of EVI1-overexpressing cancers EVI1inCancercoordinator1.499.0941
2016-01-01European Regulatory Science on Tobacco:Policy implementation to reduce lung diseases EUREST-PLUSparticipant2.325.54513
2016-01-01Mechanisms underlying hepatocellular carcinoma pathogenesis and impact of co-morbidities. HEP-CARparticipant5.698.31010
2016-01-01RNA EDITING IN HEALTH AND DISEASE RNAEDITparticipant2.270.0003
2016-01-01Towards outstanding research and training in tumour biology at IMM ReTuBiparticipant999.9753
2015-10-01implementAtion anD OPeration of the gateway for healTh into BBMRI-ERIC ADOPT BBMRI-ERICparticipant4.949.44923
2015-09-01Breast CAncer STratification: understanding the determinants of risk and prognosis of molecular subtypes B-CASTparticipant5.983.35613
2015-09-01Statistical multi-Omics UNDerstanding of Patient Samples SOUNDparticipant2.953.06313
2015-09-01Coordinated Research Infrastructures Building Enduring Life-science services CORBELparticipant14.837.80039
2015-07-01Computational Biophotonics for Endoscopic Cancer Diagnosis and Therapy COMBIOSCOPYparticipant1.499.6993
2015-07-01Regulating the immune regulators: targeting adaptive immune control REGiREGparticipant1.955.0001
2015-06-01Dissection of tumor heterogeneity in vivo CancerHeterocoordinator2.000.0001
2015-01-01Development of Selective Carbohydrate Immunomodulators Targeting C-type Lectin Receptors on Antigen Presenting Cells IMMUNOSHAPEparticipant3.811.58115
2015-01-01The RANK-Axis in Breast Cancer: A comprehensive prospective evaluation of promising novel biomarkers RANKL_OPGcoordinator168.7941

overview shows latest 50 from 89 projects (2010-01-01 - 2021-12-31)
A full list of projects can be found here:

Alias institution names:
  • DEUTSCHES KREBSFORSCHUNGSZENTRUM
  • DEUTSCHES KREBSFORSCHUNGSZENTRUM HEIDELBERG

Data provision: © European Union; Source: CORDIS, http://cordis.europa.eu/ | This page is not provided by the European Commission see:Impressum